deucravacitinib,Apremilast
bms,amgen
['psoriasis', 'deucrava', 'deucra', '$bmy']
$bmy with a huge win this morning; the fda not only approved it s new plaque psoriasis drug, deucravacitinib, but it did not impose a black box safety warning label. this label win was by no means expected or a lock because other tyk2 inhibitors like atezla got the bb label. 
I am Uhtred, son of Uhtred. Finance Professional. Anti-Woke. Cardinals baseball fan. Destiny is all!